ZA201409506B - Medicament form for release of active ingredients - Google Patents

Medicament form for release of active ingredients

Info

Publication number
ZA201409506B
ZA201409506B ZA2014/09506A ZA201409506A ZA201409506B ZA 201409506 B ZA201409506 B ZA 201409506B ZA 2014/09506 A ZA2014/09506 A ZA 2014/09506A ZA 201409506 A ZA201409506 A ZA 201409506A ZA 201409506 B ZA201409506 B ZA 201409506B
Authority
ZA
South Africa
Prior art keywords
release
active ingredients
medicament form
medicament
ingredients
Prior art date
Application number
ZA2014/09506A
Inventor
Przyklenk Karl-Heinz
Francas Gernot
Original Assignee
Hennig Arzneimittel Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hennig Arzneimittel Gmbh & Co filed Critical Hennig Arzneimittel Gmbh & Co
Publication of ZA201409506B publication Critical patent/ZA201409506B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2014/09506A 2012-06-25 2014-12-23 Medicament form for release of active ingredients ZA201409506B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012105528.9A DE102012105528A1 (en) 2012-06-25 2012-06-25 Pharmaceutical form for the release of active substances
PCT/EP2013/063162 WO2014001267A2 (en) 2012-06-25 2013-06-24 Medicament form for release of active ingredients

Publications (1)

Publication Number Publication Date
ZA201409506B true ZA201409506B (en) 2016-08-31

Family

ID=48656002

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/09506A ZA201409506B (en) 2012-06-25 2014-12-23 Medicament form for release of active ingredients

Country Status (20)

Country Link
EP (2) EP2863896B1 (en)
AU (1) AU2013283473B2 (en)
BR (1) BR112014032578B1 (en)
CA (1) CA2877190C (en)
CO (1) CO7250447A2 (en)
DE (1) DE102012105528A1 (en)
DK (1) DK2679216T3 (en)
EA (1) EA030871B1 (en)
ES (2) ES2546172T3 (en)
HU (2) HUE031246T2 (en)
IL (1) IL236466B (en)
IN (1) IN2014MN02526A (en)
MX (1) MX367284B (en)
MY (1) MY168531A (en)
PH (1) PH12014502836B1 (en)
PL (2) PL2863896T3 (en)
PT (2) PT2679216E (en)
UA (1) UA118836C2 (en)
WO (1) WO2014001267A2 (en)
ZA (1) ZA201409506B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
PL3431078T3 (en) 2017-07-20 2021-07-12 Intas Pharmaceuticals Limited Non-pulsatile prolonged-release betahistine oral solid compositions
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
DE102018129419A1 (en) 2018-11-22 2020-05-28 Johannes Gutenberg-Universität Mainz Acrylate copolymer for pharmaceutical applications

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
IT1229237B (en) * 1989-05-08 1991-07-26 Prodotti Formenti SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE
ES2051658T3 (en) * 1992-08-06 1998-06-16 Gergely Gerhard EFFERVESCENT TABLETS EASY TO MANAGE.
HRP970493A2 (en) 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
IT1309591B1 (en) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa COMPOSITIONS WITH BETAISTINE CONTROLLED RELEASE.
DE10010509A1 (en) 2000-03-08 2001-09-13 Dresden Arzneimittel Oral pharmaceutical formulations with controllable release characteristics, e.g. rapid or delayed release, contain sucrose fatty acid ester as drug release controlling agent
DE10104880A1 (en) 2001-01-31 2002-08-08 Roehm Gmbh Multiparticulate pharmaceutical form, containing at least two differently coated pellet forms
DE60320965D1 (en) * 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistine preparations with controlled release
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
US9114071B2 (en) * 2007-04-04 2015-08-25 Sigmoid Pharma Limited Oral pharmaceutical composition
US20130323309A1 (en) * 2011-02-17 2013-12-05 Lupin Limited Sustained Release Composition of Memantine

Also Published As

Publication number Publication date
HUE025739T2 (en) 2016-04-28
PT2863896T (en) 2016-12-21
UA118836C2 (en) 2019-03-25
DK2679216T3 (en) 2015-08-31
BR112014032578B1 (en) 2022-07-26
EP2679216A1 (en) 2014-01-01
PL2679216T3 (en) 2015-12-31
MX367284B (en) 2019-08-13
EP2863896B1 (en) 2016-09-14
EA030871B1 (en) 2018-10-31
ES2607447T3 (en) 2017-03-31
IN2014MN02526A (en) 2015-07-17
WO2014001267A2 (en) 2014-01-03
PT2679216E (en) 2015-10-09
HUE031246T2 (en) 2017-06-28
MX2014015660A (en) 2015-07-14
IL236466B (en) 2019-02-28
CO7250447A2 (en) 2015-04-30
BR112014032578A2 (en) 2017-06-27
AU2013283473B2 (en) 2016-10-27
EP2863896A2 (en) 2015-04-29
WO2014001267A3 (en) 2014-03-06
AU2013283473A1 (en) 2015-01-29
PH12014502836A1 (en) 2015-02-02
AU2013283473A2 (en) 2015-01-22
DE102012105528A1 (en) 2014-01-02
CA2877190A1 (en) 2014-01-03
PL2863896T3 (en) 2017-04-28
ES2546172T3 (en) 2015-09-21
EP2679216B1 (en) 2015-05-27
CA2877190C (en) 2020-01-07
IL236466A0 (en) 2015-02-26
MY168531A (en) 2018-11-12
PH12014502836B1 (en) 2015-02-02
EA201500044A1 (en) 2015-05-29

Similar Documents

Publication Publication Date Title
IL238713A0 (en) Self-regulated release of active pharmaceutical ingredient
HK1212701A1 (en) Formulations of enzalutamide
HK1197027A1 (en) Use of estetrol as emergency contraceptive
IL236465A0 (en) Pharmaceutical form for extended release of active substances
HK1203149A1 (en) Novel dosage form and formulation of abediterol
HK1208188A1 (en) Formulations for the delivery of active ingredients
IL236466B (en) Medicament form for release of active ingredients
IL239670A0 (en) Monolithic dosage form for modified release of a combination of active ingredients
PT2704698T (en) Dosage form for the controlled release of active ingredients
EP2883546A4 (en) New differential-release pharmaceutical composition containing three active principles
TH1401007646A (en) Medicament form for release of active ingredients
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
GB201104632D0 (en) Use of medicament